RG7112
Information
- Drug Name
- RG7112
- Description
- Entry(CIViC)
- 2
CIViC
Disease | Mutation | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
leukemia | TP53 WILD TYPE TP53 WILD TYPE | B |
![]() |
![]() |
Sensitivity/Response |
![]() |
3 | 26459177 | Detail |
leukemia | TP53 DELETERIOUS MUTATION TP53 DELETERIOUS MUTATION | B |
![]() |
![]() |
Resistance | Somatic | 3 | 26459177 | Detail |
Annotation
Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
---|---|---|---|---|---|---|
Phase I Trial of RG7112 in 116 heavily pretreated ... | TP53 | TP53 WILD TYPE TP53 WILD TYPE | Sensitivity | true | CIViC Evidence | detail |
Phase I Trial of MDM2 inhibitor RG7112 in 116 pati... | TP53 | TP53 DELETERIOUS MUTATION TP53 DELETERIOUS MUTATION | Resitance or Non-Reponse | true | CIViC Evidence | detail |
- Target (Drug list of Screening Committee of Anticancer Drugs)
- p53 activation
- Synonym (Drug list of Screening Committee of Anticancer Drugs)
- RO5045337